Kevin Kunzmann

How the condition affects both the vision and mindset of patients, and what clinical outcomes for anti-VEGF research do to address it.

New phase 1/2 data shows AAV-RGPR may benefit a previously untreated population of inherited retina disease boys and young men.

A look at how primary care patients begin to present with diabetic retinopathy risk.

New PANORAMA findings could give ophthalmologists confidence in longer time between administrations after year 2.

New findings evidences the device commonly used treatment in patients with VTE—despite its association with potentially new DVT development or existing DVT propagation.

How a decades-long issue has resulted in at-need patients lacking confident, available physicians.

An expert explains why little progress has been made in disease prevalence and burden in the US.

The vaccine induced T cell response in about 2 weeks, and antibody response in about 4 weeks, among 1000-plus healthy adults.

A secondary ACCELERATE assessment shows a particular set of patients who may benefit from Lp(a)-lowering novel agents.

The first prospective safety trial using oral factor Xa inhibitor in patients undergoing laparotomy shows women preferred and adhered to the drug.

The COVID-19 vaccine candidate, mRNA-1273, induced immune responses in all 45 of its volunteer patients administered doses.

The practice of genetic testing has been useful in clinically addressing found cases of familial hypercholesterolemia, among other conditions, but no clinical practice guidelines currently exist for testing patients with suspected hereditary dyslipidemia.

What does personalized outpatient care look like for a cardiology institute during the pandemic?

A study shows surveyed patients were nearly twice as likely to be satisfied with the care they receive from a usual clinician than an emergency caregiver.

A streamlined testing procedure in sub-Saharan Africa shows improved infant and newborn patient identification.

A majority of those who fall under the criteria for recommended HIV testing has not once received such testing.

Genomics, in combination with patient demographic risks, could help better inform clinicians of persons at risk for worsened chronic pulmonary burden.

A noninferiority study showed parents were not more anxious when their discharged child was treated as-need—nor was their child at greater health risk.

New research shows patients with both conditions have greater levels of particular cytokines and metabolic proteins.

A look at the risks patients face due to the pandemic—and what minority patients may face daily.

A look at the quarter of available drugs for the rare disease, and how they fare in relation to evolving understanding of disease effect.

ADHD, autism spectrum disorder, seizures, and even developmental delays are asssociated with a two-fold risk of asthma in US children.

Where do investigators go next with the 8000-plus COPD patient research?

In an era of triple therapy combinations, what might a tailored approach look like?

New findings from the 8000-plus patient ETHOS trial shows triple inhaler therapy siginificantly betters patient mortality and symptoms over 52 weeks versus dual therapy.

After promising early findings for the investigative therapy in a rare form of blindness, investigators turn to the next phase.

Ken Ataga, MD, discusses new developments in interpreting the condition's progression and effect on patients.

A 20-year dream becomes a necessity in the days after COVID-19 began to spike. Who helped to bring it practice, and what does it look like now?

More than three-fourths of online respondents expressed concern about providing in-person patient safety after COVID-19. Another 35% want to use telemedicine in their practice now.

Gauging patient wellbeing prior to intravitreal injections may help inform clinicians as to who may fare worse with the treatment.